Tazarotene Gel
Product Images NDC 73473-309

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tazarotene (NDC 73473-309). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Solaris Pharma Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton-005 (Tazarotene Gel 005 Carton 100g)

The packaging label for Tazarotene Gel 0.05%, a cutaneous gel dosage form. The label shows a 100-gram size with directions indicating use for dermatologic purposes only, not ophthalmic use. The labeler is Solaris Pharma Corporation. The design features an orange and blue color scheme with dosage and ingredient information included.*

FDA Label Image

Carton-01 (Tazarotene Gel 01 Carton 100g)

Packaging label for Tazarotene Gel 0.1%, a topical prescription gel by Solaris Pharma Corporation. The label indicates a 100 gram tube, for dermatologic use only and not for ophthalmic use. It includes dosage instructions, active and inactive ingredients, storage conditions, and a barcode.*

FDA Label Image

Structure (Tazarotene Gel Structure1)

Chemical structure of the active ingredient Tazarotene, showing its molecular framework typical for this compound used in topical gels by Solaris Pharma Corporation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.